APA (7th ed.) Citation

Gebhardt, C., Simon, S. C. S., Bitsch, R., Gries, M., Mun, D. H., Reinhard, R., . . . Utikal, J. (2021). Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade: A pilot study. Cellular immunology, 360, . https://doi.org/10.1016/j.cellimm.2020.104274

Chicago Style (17th ed.) Citation

Gebhardt, Christoffer, Sonja C. S. Simon, Rebekka Bitsch, Mirko Gries, Dong Hun Mun, Raphael Reinhard, Tim Holland-Letz, Viktor Umansky, and Jochen Utikal. "Potential Therapeutic Effect of Low-dose Paclitaxel in Melanoma Patients Resistant to Immune Checkpoint Blockade: A Pilot Study." Cellular Immunology 360 (2021). https://doi.org/10.1016/j.cellimm.2020.104274.

MLA (9th ed.) Citation

Gebhardt, Christoffer, et al. "Potential Therapeutic Effect of Low-dose Paclitaxel in Melanoma Patients Resistant to Immune Checkpoint Blockade: A Pilot Study." Cellular Immunology, vol. 360, 2021, https://doi.org/10.1016/j.cellimm.2020.104274.